PsyRx
Drug Development Using Biological Bioreactor Technology
Active
Seed
Startup
Tel Aviv-Yafo
Founded 2019-10
PsyRx is a pharmaceutical R&D company developing biological API psilocybin and ibogaine in accordance with GMP standards. Using biological bioreactor technology, the company is focused on becoming a leading producer of GMP-standard ibogaine and psilocybin for use by target customers in the development and production of psychedelic- and ibogaine-based pharma…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$2.4M
Employees5
Founded2019-10
HQTel Aviv-Yafo
Patents1
Confidence99
Sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals